Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadja Kopp

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Vaccine|October 8, 2009
Identification of a synthetic peptide inducing cross-reactive antibodies binding to Rhipicephalus (Boophilus) decoloratus, Rhipicephalus (Boophilus) microplus, Hyalomma anatolicum anatolicum and Rhipicephalus appendiculatus BM86 homologuesNadja Kopp, Diana Diaz, Mario Amacker, et al.
Blood|August 24, 2012
Differences in signaling through the B-cell leukemia oncoprotein CRLF2 in response to TSLP and through mutant JAK2Diederik van Bodegom, Jun Zhong, Nadja Kopp, et al.
Blood|August 21, 2012
BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemiaChristopher J Ott, Nadja Kopp, Liat Bird, et al.
Plos One|November 13, 2012
Next-generation cDNA screening for oncogene and resistance phenotypesNobuaki Shindoh, Akinori Yoda, Yuka Yoda, et al.
Oncotarget|June 11, 2016
Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclonesThomas Melchardt, Clemens Hufnagl, David M Weinstock, et al.
Cancer Research|June 13, 2012
BCL2 suppresses PARP1 function and nonapoptotic cell deathChaitali Dutta, Tovah Day, Nadja Kopp, et al.
Blood Advances|January 4, 2018
Targetable subsets of non-Hodgkin lymphoma in Malawi define therapeutic opportunitiesElizabeth A Morgan, M Patrick Sweeney, Tamiwe Tomoka, et al.
Blood|October 16, 2016
HSP90 inhibition overcomes ibrutinib resistance in mantle cell lymphomaCaron Jacobson, Nadja Kopp, Jacob V Layer, et al.
Cancer Discovery|May 16, 2012
Molecular ontogeny of donor-derived follicular lymphomas occurring after hematopoietic cell transplantationOliver Weigert, Nadja Kopp, Andrew A Lane, et al.
Blood|December 19, 2013
A targeted mutational landscape of angioimmunoblastic T-cell lymphomaOreofe Odejide, Oliver Weigert, Andrew A Lane, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Vaccine|October 8, 2009
Identification of a synthetic peptide inducing cross-reactive antibodies binding to Rhipicephalus (Boophilus) decoloratus, Rhipicephalus (Boophilus) microplus, Hyalomma anatolicum anatolicum and Rhipicephalus appendiculatus BM86 homologuesNadja Kopp, Diana Diaz, Mario Amacker, et al.
Blood|August 24, 2012
Differences in signaling through the B-cell leukemia oncoprotein CRLF2 in response to TSLP and through mutant JAK2Diederik van Bodegom, Jun Zhong, Nadja Kopp, et al.
Blood|August 21, 2012
BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemiaChristopher J Ott, Nadja Kopp, Liat Bird, et al.
Plos One|November 13, 2012
Next-generation cDNA screening for oncogene and resistance phenotypesNobuaki Shindoh, Akinori Yoda, Yuka Yoda, et al.
Oncotarget|June 11, 2016
Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclonesThomas Melchardt, Clemens Hufnagl, David M Weinstock, et al.
Cancer Research|June 13, 2012
BCL2 suppresses PARP1 function and nonapoptotic cell deathChaitali Dutta, Tovah Day, Nadja Kopp, et al.
Blood Advances|January 4, 2018
Targetable subsets of non-Hodgkin lymphoma in Malawi define therapeutic opportunitiesElizabeth A Morgan, M Patrick Sweeney, Tamiwe Tomoka, et al.
Blood|October 16, 2016
HSP90 inhibition overcomes ibrutinib resistance in mantle cell lymphomaCaron Jacobson, Nadja Kopp, Jacob V Layer, et al.
Cancer Discovery|May 16, 2012
Molecular ontogeny of donor-derived follicular lymphomas occurring after hematopoietic cell transplantationOliver Weigert, Nadja Kopp, Andrew A Lane, et al.
Blood|December 19, 2013
A targeted mutational landscape of angioimmunoblastic T-cell lymphomaOreofe Odejide, Oliver Weigert, Andrew A Lane, et al.
Pageof 2